Department of Otorhinolaryngology, Head, and Neck Surgery, The Queen Elizabeth Hospital, Woodville, South Australia, Australia.
Curr Allergy Asthma Rep. 2012 Apr;12(2):127-35. doi: 10.1007/s11882-012-0246-7.
Chronic rhinosinusitis (CRS) is a very common condition that remains poorly understood from a pathogenic standpoint. Recent interest has been sparked by a potential role for biofilms in this process, with a significant body of evidence implicating them in inciting sinonasal inflammation. Biofilms are clearly present on the sinus mucosa of CRS patients, and their presence there is associated with severe disease characteristics and surgical recalcitrance. We are beginning to understand the importance of the species within these biofilms, but there may be other as-yet-unidentified factors at play in influencing disease outcomes. Recent exciting research has emerged documenting the immune response to the presence of biofilms-research that will ultimately solidify the nature and extent of the contribution of biofilms in CRS pathogenesis. Future research should focus on evidence-based antibiofilm treatments with reference to efficacy and timing of treatment.
慢性鼻-鼻窦炎(CRS)是一种非常常见的疾病,但从发病机制的角度来看,人们对此仍了解甚少。最近,生物膜在这一过程中可能发挥的作用引起了人们的兴趣,大量证据表明它们会引发鼻窦炎症。生物膜在 CRS 患者的鼻窦黏膜上明显存在,其存在与严重的疾病特征和手术难治性有关。我们开始了解这些生物膜中物种的重要性,但在影响疾病结果方面,可能还有其他尚未确定的因素在起作用。最近出现了一些令人兴奋的研究,记录了对生物膜存在的免疫反应——这些研究最终将确定生物膜在 CRS 发病机制中的性质和程度。未来的研究应该集中在基于证据的抗生物膜治疗上,并参考治疗的效果和时机。